Bacainn Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Bacainn Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase 1, Single-Ascending-Dose Study of BT051 in Healthy Subjects (NCT05103878) | Bacainn Therapeutics, Inc. | 2020-06-24 |
Track Bacainn Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.